These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34462900)

  • 1. Echocardiographic assessment of cardiac amyloidosis.
    Agrawal T; Nagueh SF
    Heart Fail Rev; 2022 Sep; 27(5):1505-1513. PubMed ID: 34462900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging.
    Di Nunzio D; Recupero A; de Gregorio C; Zito C; Carerj S; Di Bella G
    Curr Cardiol Rep; 2019 Feb; 21(2):7. PubMed ID: 30747298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Echocardiographic analysis in cardiac amyloidosis].
    Hurrel C; Deriaz-Chessex S; Waeber G; Jeanrenaud X; Périard D
    Praxis (Bern 1994); 2006 Jun; 95(24):977-81. PubMed ID: 16802507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.
    White JA; Fine NM
    Curr Cardiol Rep; 2016 Aug; 18(8):77. PubMed ID: 27319007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiography in cardiac amyloidosis.
    Falk RH; Quarta CC
    Heart Fail Rev; 2015 Mar; 20(2):125-31. PubMed ID: 25597027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advance of echocardiography in cardiac amyloidosis.
    Liang S; Liu Z; Li Q; He W; Huang H
    Heart Fail Rev; 2023 Nov; 28(6):1345-1356. PubMed ID: 37558934
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Saad JM; Ahmed AI; Han Y; Saeed S; Pournazari P; Al-Mallah MH
    Heart Fail Rev; 2022 Sep; 27(5):1493-1503. PubMed ID: 34709500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Standard Echocardiographic Parameters in Endomyocardial Biopsy Proven Cardiac Amyloidosis.
    Biočić S; Jurinjak SJ; Vincelj J; Barić D; Manojlović S; Brkljačić DD
    Coll Antropol; 2015 Jun; 39(2):441-5. PubMed ID: 26753463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of infiltrative cardiomyopathies resulting in heart failure with preserved ejection fraction.
    Madan N; Kalra D
    Rev Cardiovasc Med; 2020 Jun; 21(2):181-190. PubMed ID: 32706207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis.
    Saad JM; Ahmed AI; Anugula D; Han Y; Alfawara MS; Al-Mallah MH
    Methodist Debakey Cardiovasc J; 2022; 18(2):47-58. PubMed ID: 35414854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis: A case series and literature review.
    Costache II; Buburuz AM; Crisu D; Statescu AM; Ungureanu C; Aursulesei V
    Medicine (Baltimore); 2019 Sep; 98(38):e17256. PubMed ID: 31567998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy.
    Suresh R; Grogan M; Maleszewski JJ; Pellikka PA; Hanna M; Dispenzieri A; Pereira NL
    J Am Soc Echocardiogr; 2014 Apr; 27(4):440-7. PubMed ID: 24444660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art.
    Popescu C; Burger IA
    Curr Radiopharm; 2021; 14(3):228-241. PubMed ID: 32525789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality imaging for the diagnosis of infiltrative cardiomyopathies.
    Vidula MK; Bravo PE
    Heart; 2022 Jan; 108(2):98-104. PubMed ID: 34039679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac amyloidosis.
    Martinez-Naharro A; Hawkins PN; Fontana M
    Clin Med (Lond); 2018 Apr; 18(Suppl 2):s30-s35. PubMed ID: 29700090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic imaging of cardiac amyloidosis.
    Martinez-Naharro A; Baksi AJ; Hawkins PN; Fontana M
    Nat Rev Cardiol; 2020 Jul; 17(7):413-426. PubMed ID: 32042139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
    Löfbacka V; Suhr OB; Pilebro B; Wixner J; Sundström T; Lindmark K; Anan I; Lindqvist P
    Clin Physiol Funct Imaging; 2021 Sep; 41(5):408-416. PubMed ID: 34033209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
    Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
    Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis.
    Verrillo F; Palmiero G; Monda E; Dongiglio F; Diana G; Sinagra G; Emdin M; Limongelli G
    Heart Fail Clin; 2024 Jul; 20(3):271-282. PubMed ID: 38844298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.